Sartorius Ag (SARTF) Upgraded at Zacks Investment Research
Zacks Investment Research upgraded shares of Sartorius Ag (NASDAQ:SARTF) from a hold rating to a buy rating in a report issued on Tuesday. The firm currently has $106.00 target price on the stock.
According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
Separately, DZ Bank AG reiterated a sell rating on shares of Sartorius Ag in a research note on Friday, June 2nd.
Shares of Sartorius Ag (NASDAQ:SARTF) opened at 96.00 on Tuesday. Sartorius Ag has a 52 week low of $75.00 and a 52 week high of $96.00. The firm has a market capitalization of $6.57 billion and a price-to-earnings ratio of 54.45.
ILLEGAL ACTIVITY WARNING: “Sartorius Ag (SARTF) Upgraded at Zacks Investment Research” was reported by Daily Political and is the property of of Daily Political. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/09/16/sartorius-ag-sartf-upgraded-at-zacks-investment-research.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.